Dow Up 0.35% Nasdaq Down 0.02%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
2.55 Down 0.01(0.39%) 4:00PM EDT
Prev Close:2.56
Open:2.54
Bid:1.95 x 5000
Ask:2.91 x 6000
1y Target Est:4.90
Beta:1.64
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:2.51 - 2.65
52wk Range:1.07 - 4.25
Volume:1,076,498
Avg Vol (3m):1,617,140
Market Cap:368.36M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CTIC

Comparison

Symbol% ChgMkt Cap
CTICDown 0.39%368.36M
BMYDown 0.52%82.96B
RHHBYDown 0.52%247.66B
SNYDown 0.94%138.53B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.27
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.61
Quarterly EPS Est (Sep-14) :-0.04
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback